Across TCGA patient cohorts, RPL17P13 RNA expression is significantly associated with the protein abundance of many other proteins, with 7,841 significant associations in total. GBM shows the largest number of these associations.

The most reproducible RPL17P13-associated proteins across cancer lineages are TOP2B, TRADD, and ARID2. Each is linked with RPL17P13 in more than 3 cancer types. Because this analysis shows association rather than direction, both RPL17P13-to-partner and partner-to-RPL17P13 results are reported.

Each partner links to its own Q-omics profile.

RNA expression associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (RPL17P13→partner) and Y-score (partner→RPL17P13) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner protein	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
GBM	TOP2B →	+0.273	+0.448	<.001	<.001	3	4
GBM	TRADD →	-0.385	-0.623	<.001	<.001	3	4
HNSC	ARID2 →	+0.189	+0.455	.004	.005	3	4
GBM	MYO1G →	-0.499	-0.524	<.001	<.001	3	4
LSCC	ORC5 →	+0.251	+0.412	.009	.007	3	4
LSCC	DOCK10 →	-0.426	-0.674	<.001	<.001	3	4

Each partner links to its Q-omics profile. Showing the 6 strongest of 7,841 associations by consensus.

Exploration

RPL17P13 survival (RNA) · tumor vs normal (RNA) · all RPL17P13 data types